Hansa Biopharma — Major Shareholding Notification 2020

Nov 30, 2020

Issuer Hansa Biopharma AB

Holder

Redmile Group, LLC

Instrument

Instrument	Ordinary shares SE0002148817
Before the transaction
Shares	4,491,442
Voting rights	4,491,442
Transaction
Reason for major shareholding notification Buy
Date	24/11/2020
Limit for number of shares	10 %
After the transaction
Quantity
Shares	4,625,590
Directly held voting rights	0
Indirectly held voting rights	4,625,590
Percentage
Directly held shares	10.07866 %
Directly held voting rights	0 %
Indirectly held voting rights	10.36765 %
Resulting distribution of total

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	10.36765 %	4,625,590
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	10.36765 %	4,625,590

Chain of controlling companies

	Voting rights % Voting rights Company
907,522	2.03409	Redmile Capital Fund, LP
1,819,476 4.07812		Redmile Capital Offshore Master Fund, Ltd.
82,568	0.18507	Redmile Capital Offshore Master Fund (ERISA), Ltd.
555,476	1.24503	Redmile Capital Offshore II Master Fund, Ltd.
752,082	1.68569	Redmile Strategic Master Fund, LP
357,288	0.80081	RedCo I, L.P
151,178	0.33885	Map 20 Segregated Portfolio a Segregated Portfolio of LMA SPC

Group total holdings

Voting rights 4,625,590 Percentage of voting rights 10.36765

Published

30/11/2020 12:06

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25